{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:03:14Z","timestamp":1791223394224,"version":"4.1.0"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Stroke"],"published-print":{"date-parts":[[2001,12]]},"abstract":"<jats:p>\n            <jats:bold>\n              <jats:italic>\n                <jats:bold>\n                  <jats:italic>Background and Purpose<\/jats:italic>\n                <\/jats:bold>\n                \u2014\n              <\/jats:italic>\n            <\/jats:bold>\n            Although risk factors for carotid artery stenosis caused by atherosclerosis are known, it is unclear what triggers \u201cactivation\u201d of the atherosclerotic plaques and the ensuing thromboembolic cerebral events. The aim of this study was to evaluate whether thrombophilic factors, platelet glycoprotein (GP) polymorphisms, and homocysteine are associated with a risk of ischemic events in patients with significant carotid stenosis.\n          <\/jats:p>\n          <jats:p>\n            <jats:bold>\n              <jats:italic>\n                <jats:bold>\n                  <jats:italic>Methods<\/jats:italic>\n                <\/jats:bold>\n                \u2014\n              <\/jats:italic>\n            <\/jats:bold>\n            Consecutive patients with \u226550% carotid stenosis, whether symptomatic (with ipsilateral ischemic events) or asymptomatic, who were evaluated and followed in a neurovascular clinic were tested for plasma levels of homocysteine, C677T mutation in methylenetetrahydrofolate reductase, G20210A mutation of factor II, factor V Leiden, antiphospholipid antibodies, and polymorphisms of platelet membrane GP: human platelet antigen (HPA)-1, GP Ia (C807T), and GP Ib (variable number of tandem repeats, Kozak, and HPA-2).\n          <\/jats:p>\n          <jats:p>\n            <jats:bold>\n              <jats:italic>\n                <jats:bold>\n                  <jats:italic>Results<\/jats:italic>\n                <\/jats:bold>\n                \u2014\n              <\/jats:italic>\n            <\/jats:bold>\n            Eighty-six asymptomatic and 67 symptomatic patients were evaluated. The former group was older (73.7\u00b16.9 versus 69.5\u00b19.1 years,\n            <jats:italic>P<\/jats:italic>\n            =0.02). Major risk factors for stroke were similar in both groups. In symptomatic patients versus asymptomatic patients, hyperhomocysteinemia was 3-fold more frequent (34.3% versus 12.8%, respectively;\n            <jats:italic>P<\/jats:italic>\n            =0.002) and HPA-1a\/b was almost 2-fold more common (38.8% versus 20.9%, respectively;\n            <jats:italic>P<\/jats:italic>\n            =0.01). All other thrombophilic factors and platelet polymorphisms studied did not differ significantly between the 2 groups. Multivariate analysis revealed that hyperhomocysteinemia and the HPA-1a\/b genotype conferred a significant risk of cerebral ischemic events, with odds ratios (95% CI) of 4.07 (1.7 to 9.7) and 3.4 (1.5 to 7.8), respectively.\n          <\/jats:p>\n          <jats:p>\n            <jats:bold>\n              <jats:italic>\n                <jats:bold>\n                  <jats:italic>Conclusions<\/jats:italic>\n                <\/jats:bold>\n                \u2014\n              <\/jats:italic>\n            <\/jats:bold>\n            Hyperhomocysteinemia and HPA-1a\/b are independent risk factors for ischemic events in patients with significant carotid stenosis.\n          <\/jats:p>","DOI":"10.1161\/hs1201.099650","type":"journal-article","created":{"date-parts":[[2007,10,10]],"date-time":"2007-10-10T17:48:04Z","timestamp":1192038484000},"page":"2753-2758","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":34,"title":["Cerebrovascular Events in Patients With Significant Stenosis of the Carotid Artery Are Associated With Hyperhomocysteinemia and Platelet Antigen-1 (Leu33Pro) Polymorphism"],"prefix":"10.1161","volume":"32","author":[{"given":"J.Y.","family":"Streifler","sequence":"first","affiliation":[{"name":"From the Neurology Unit (J.Y.S), Rabin Medical Center, Golda Campus, Petach-Tikva, Israel, and the Institutes of Thrombosis and Hemostasis (N.R., R.E, R.D, A.Z, B.R., J.D., U.S., A.I.), Clinical Epidemiology (A.C.), and Chemical Pathology (B.A.S.), Sheba Medical Center, Tel Hashomer and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Rosenberg","sequence":"additional","affiliation":[{"name":"From the Neurology Unit (J.Y.S), Rabin Medical Center, Golda Campus, Petach-Tikva, Israel, and the Institutes of Thrombosis and Hemostasis (N.R., R.E, R.D, A.Z, B.R., J.D., U.S., A.I.), Clinical Epidemiology (A.C.), and Chemical Pathology (B.A.S.), Sheba Medical Center, Tel Hashomer and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Chetrit","sequence":"additional","affiliation":[{"name":"From the Neurology Unit (J.Y.S), Rabin Medical Center, Golda Campus, Petach-Tikva, Israel, and the Institutes of Thrombosis and Hemostasis (N.R., R.E, R.D, A.Z, B.R., J.D., U.S., A.I.), Clinical Epidemiology (A.C.), and Chemical Pathology (B.A.S.), Sheba Medical Center, Tel Hashomer and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Eskaraev","sequence":"additional","affiliation":[{"name":"From the Neurology Unit (J.Y.S), Rabin Medical Center, Golda Campus, Petach-Tikva, Israel, and the Institutes of Thrombosis and Hemostasis (N.R., R.E, R.D, A.Z, B.R., J.D., U.S., A.I.), Clinical Epidemiology (A.C.), and Chemical Pathology (B.A.S.), Sheba Medical Center, Tel Hashomer and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.A.","family":"Sela","sequence":"additional","affiliation":[{"name":"From the Neurology Unit (J.Y.S), Rabin Medical Center, Golda Campus, Petach-Tikva, Israel, and the Institutes of Thrombosis and Hemostasis (N.R., R.E, R.D, A.Z, B.R., J.D., U.S., A.I.), Clinical Epidemiology (A.C.), and Chemical Pathology (B.A.S.), Sheba Medical Center, Tel Hashomer and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Dardik","sequence":"additional","affiliation":[{"name":"From the Neurology Unit (J.Y.S), Rabin Medical Center, Golda Campus, Petach-Tikva, Israel, and the Institutes of Thrombosis and Hemostasis (N.R., R.E, R.D, A.Z, B.R., J.D., U.S., A.I.), Clinical Epidemiology (A.C.), and Chemical Pathology (B.A.S.), Sheba Medical Center, Tel Hashomer and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Zivelin","sequence":"additional","affiliation":[{"name":"From the Neurology Unit (J.Y.S), Rabin Medical Center, Golda Campus, Petach-Tikva, Israel, and the Institutes of Thrombosis and Hemostasis (N.R., R.E, R.D, A.Z, B.R., J.D., U.S., A.I.), Clinical Epidemiology (A.C.), and Chemical Pathology (B.A.S.), Sheba Medical Center, Tel Hashomer and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Ravid","sequence":"additional","affiliation":[{"name":"From the Neurology Unit (J.Y.S), Rabin Medical Center, Golda Campus, Petach-Tikva, Israel, and the Institutes of Thrombosis and Hemostasis (N.R., R.E, R.D, A.Z, B.R., J.D., U.S., A.I.), Clinical Epidemiology (A.C.), and Chemical Pathology (B.A.S.), Sheba Medical Center, Tel Hashomer and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Davidson","sequence":"additional","affiliation":[{"name":"From the Neurology Unit (J.Y.S), Rabin Medical Center, Golda Campus, Petach-Tikva, Israel, and the Institutes of Thrombosis and Hemostasis (N.R., R.E, R.D, A.Z, B.R., J.D., U.S., A.I.), Clinical Epidemiology (A.C.), and Chemical Pathology (B.A.S.), Sheba Medical Center, Tel Hashomer and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Seligsohn","sequence":"additional","affiliation":[{"name":"From the Neurology Unit (J.Y.S), Rabin Medical Center, Golda Campus, Petach-Tikva, Israel, and the Institutes of Thrombosis and Hemostasis (N.R., R.E, R.D, A.Z, B.R., J.D., U.S., A.I.), Clinical Epidemiology (A.C.), and Chemical Pathology (B.A.S.), Sheba Medical Center, Tel Hashomer and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Inbal","sequence":"additional","affiliation":[{"name":"From the Neurology Unit (J.Y.S), Rabin Medical Center, Golda Campus, Petach-Tikva, Israel, and the Institutes of Thrombosis and Hemostasis (N.R., R.E, R.D, A.Z, B.R., J.D., U.S., A.I.), Clinical Epidemiology (A.C.), and Chemical Pathology (B.A.S.), Sheba Medical Center, Tel Hashomer and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_1_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.23.12.1448826"},{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.24.1.35"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200006083422302"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1995.03520420037035"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199901143400207"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199804093381507"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199502023320502"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)04470-0"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.31.3.774"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.28.1.95"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-996025"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1614842"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199504063321403"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.10.3562"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.31.6.1283"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.28.9.1739"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.29.4.869"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.31.5.1069"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-117-12-997"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.43.10.2069"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.31.6.1289"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)92407-8"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.29.12.2473"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-131-5-199909070-00006"},{"key":"e_1_3_1_25_2","doi-asserted-by":"crossref","unstructured":"Kunicki TJ. Platelet antigen polymorphisms.In: Platelets: New Understanding of Platelet Glycoproteins and Their Role in Disease: Hematology 2000 December 1\u20135 2000. San Francisco Calif: American Society of Hematology; 2000.Education program book.","DOI":"10.1182\/asheducation.V2000.1.222.20000222"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.31.7.1628"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1615851"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V93.11.3583"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1614605"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V92.8.2771"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.31.2.493"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.4.875"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1613751"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1161\/atvb.19.10.2573"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)80010-4"},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.1177\/204748739900600103"},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02620.x"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.29.3.581"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.20.10.2799873"},{"key":"e_1_3_1_40_2","unstructured":"Otis SM Ringelstein EB. The transcranial Doppler examination: principles and applications of transcranial Doppler sonography.In: Tegeler CH Babikian UL Gomez CR eds. Neurosonology. St Louis Mo: CV Mosby Co; 1996: 113\u2013128."},{"key":"e_1_3_1_41_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/40.6.873"},{"key":"e_1_3_1_42_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/16.3.1215"},{"key":"e_1_3_1_43_2","doi-asserted-by":"publisher","DOI":"10.1161\/atvb.19.3.511"},{"key":"e_1_3_1_44_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0595-111"},{"key":"e_1_3_1_45_2","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1182\/blood.V81.3.835.bloodjournal813835","volume":"81","year":"1993","unstructured":"Simsek S, Faber NM, Bleeker PM, Vlekke ABJ, Huiskes E, Goldschmeding R, von dem Borne AEG Jr. Determination of human platelet antigen frequencies in the Dutch population by immunophenotyping and DNA (allele-specific restriction enzyme) analysis. Blood. 1993; 81: 835\u2013840.","journal-title":"Blood"},{"key":"e_1_3_1_46_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.4.1357.bloodjournal8641357"},{"key":"e_1_3_1_47_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.29.12.2478"},{"key":"e_1_3_1_48_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.31.12.2907"}],"container-title":["Stroke"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/hs1201.099650","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T02:17:47Z","timestamp":1715653067000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/hs1201.099650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12]]},"references-count":48,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2001,12]]}},"alternative-id":["10.1161\/hs1201.099650"],"URL":"https:\/\/doi.org\/10.1161\/hs1201.099650","relation":{},"ISSN":["0039-2499","1524-4628"],"issn-type":[{"value":"0039-2499","type":"print"},{"value":"1524-4628","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,12]]},"assertion":[{"value":"2001-06-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-08-30","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-12-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}